Chris WilfongOperating Partner
Christopher Wilfong is an Operating Partner at Two River, and has been a co-founder and held interim management roles in several Two River portfolio companies including Kite Pharma, Inc. (KITE), Arno Therapeutics, Inc. (ARNI.OB), and Nile Therapeutics, Inc. (acquired by Capricor Therapeutics, CAPR). He currently serves as the COO of Kronos Bio, Inc. Prior to Two River, Mr. Wilfong was a Director at Trustbridge Partners, a China-based growth equity firm, where he led the US investment team and negotiated multiple US-China joint ventures and strategic partnerships in the healthcare and media industries. Prior to that, he was a Consultant at Bain & Company.